Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice.

  • Authors : Shibuya M; Laboratory of Nano-design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.; Vaccine Creation Project, BIKEN Center for Innovative Vaccine Research and Development, The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan.

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*biosynthesis ; Immunoglobulin G/Immunoglobulin G/Immunoglobulin G/*biosynthesis

  • Source: Journal of virology [J Virol] 2020 Jun 01; Vol. 94 (12). Date of Electronic Publication: 2020 Jun 01 (Print Publication: 2020).Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model:

Record details

×
Academic Journal

Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.

  • Authors : Kasturi SP; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, USA.; Kozlowski PA

Subjects: Adjuvants, Immunologic* ; Nanoparticles*; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology

  • Source: Journal of virology [J Virol] 2017 Jan 31; Vol. 91 (4). Date of Electronic Publication: 2017 Jan 31 (Print Publication: 2017).Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model:

Record details

×
Academic Journal

Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant.

  • Authors : Chen WH; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA .; Jackson LA

Subjects: Adjuvants, Immunologic*; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood ; Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/*immunology

  • Source: Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2015 Nov 11; Vol. 23 (1), pp. 73-7. Date of Electronic Publication: 2015 Nov 11 (Print Publication: 2016).Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101252125 Publication Model:

Record details

×
Academic Journal

Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.

  • Authors : Beljanski V; Vaccine & Gene Therapy Institute of Florida, Port St. Lucie, Florida, USA.; Chiang C

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*biosynthesis ; DEAD-box RNA Helicases/DEAD-box RNA Helicases/DEAD-box RNA Helicases/*immunology

  • Source: Journal of virology [J Virol] 2015 Oct; Vol. 89 (20), pp. 10612-24. Date of Electronic Publication: 2015 Aug 12.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model:

Record details

×
Academic Journal

Long-term immunogenicity of an inactivated split-virion 2009 pandemic influenza A H1N1 virus vaccine with or without aluminum adjuvant in mice.

  • Authors : Xu W; Shanghai Institute of Biological Products, Shanghai, China School of Life Sciences, Fudan University, Shanghai, China.; Zheng M

Subjects: Adjuvants, Immunologic*; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood ; Influenza A Virus, H1N1 Subtype/Influenza A Virus, H1N1 Subtype/Influenza A Virus, H1N1 Subtype/*immunology

  • Source: Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2015 Mar; Vol. 22 (3), pp. 327-35. Date of Electronic Publication: 2015 Jan 14.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101252125 Publication Model:

Record details

×
Academic Journal

Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.

  • Authors : Hensel MT; Vaccine Platform Group, MedImmune, Gaithersburg, Maryland, USA .; Marshall JD

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*pharmacology ; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*blood ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood

  • Source: Journal of virology [J Virol] 2017 Apr 13; Vol. 91 (9). Date of Electronic Publication: 2017 Apr 13 (Print Publication: 2017).Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model:

Record details

×
Academic Journal

Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects.

  • Authors : Bihari I; Pestszentlőrinc-Pestszentimre Health Service KFT, Budapest, Hungary.; Pánczél G

Subjects: Cross Reactions*; Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood

  • Source: Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2012 Dec; Vol. 19 (12), pp. 1943-8. Date of Electronic Publication: 2012 Oct 17.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101252125 Publication Model:

Record details

×
Academic Journal

Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination.

  • Authors : Karlsson EA; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Hertz T

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*blood ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood

  • Source: MBio [mBio] 2016 Aug 02; Vol. 7 (4). Date of Electronic Publication: 2016 Aug 02.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model:

Record details

×
Academic Journal

A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly.

  • Authors : Fragapane E; Novartis Vaccines and Diagnostics, Via Fiorentina, 1, 53100 Siena, Italy. ; Gasparini R

Subjects: Cross Reactions*; Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood

  • Source: Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2010 Nov; Vol. 17 (11), pp. 1817-9. Date of Electronic Publication: 2010 Sep 01.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101252125 Publication Model:

Record details

×
Academic Journal

An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

  • Authors : Khalil SM; Global Vaccines Inc., Research Triangle Park, North Carolina, USA Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Tonkin DR

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Alphavirus/Alphavirus/Alphavirus/*immunology ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology

  • Source: Journal of virology [J Virol] 2014 Aug; Vol. 88 (16), pp. 9182-96. Date of Electronic Publication: 2014 Jun 04.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model:

Record details

×
  • 1-10 of  45 results for "%22Adjuvants%2C Immunologic%22"